<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320921">
  <stage>Registered</stage>
  <submitdate>8/12/2009</submitdate>
  <approvaldate>14/12/2009</approvaldate>
  <actrnumber>ACTRN12609001069246</actrnumber>
  <trial_identification>
    <studytitle>Loading Dose Vitamin D Study: Cholecalciferol 5000units daily compared to 1000units daily for the treatment of moderate to severe vitamin D deficiency in Elderly Patients (LDVD Study)</studytitle>
    <scientifictitle>Loading Dose Vitamin D Study: Cholecalciferol 5000units daily compared to 1000units daily for the treatment of moderate to severe vitamin D deficiency in Elderly Patients (LDVD Study)</scientifictitle>
    <utrn>NA</utrn>
    <trialacronym>LDVD Study</trialacronym>
    <secondaryid>Registered Project 421/09</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Elderly Patients with moderate to severe Vitamin D deficiency</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Normal metabolism and endocrine development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients will be treated with Cholecalciferol 5000units orally daily (five tablets) with 600mg Caltrate(R) orally daily (one tablet) for 12 weeks</interventions>
    <comparator>Patients will be treated with Cholecalciferol 1000units with 600mg Caltrate(R) daily for 12 weeks</comparator>
    <control>Dose comparison</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Percentage of patients with vitamin D level above 75nmol/L at week 12 in the two groups</outcome>
      <timepoint>Vitamin D levels will be taken at baseline and week 12</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All elderly patients above the age of 65 years old admitted to The Alfred, Caulfield, Sandringham Hospital during study period with moderate to severe vitamin D deficiency (&lt;25nmol/L) with risk factors for osteoporosis as per National Prescribing Service (NPS) guidelines.</inclusivecriteria>
    <inclusiveminage>65</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Patients with severe renal dysfunction Estimated Glomerular Filtration Rate (eGFR) less than 10mL/min estimated by Cockcroft Gault formula will be excluded due to their inability to convert cholecalciferol into the activated vitamin D form for use in the body. These patients need to be treated with 1,25 dihydroxyvitamin D.
Patients who have been stabilised on continuous cholecalciferol treatment for more than 6 weeks will be excluded from the trial. Patients who have been on cholecalciferol 1000units or less for a period of less than six weeks treatment would still be considered for enrolment. This is based on the assumption that these patients will not reach steady state due to the long half life of cholecalciferol (~3 weeks). 
Patients with swallowing difficulties, currently there are only oral formulations available in Australia therefore it would be not feasible to enrol these patients into the trial.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients with vitamin D level of less than 25nmol/L will be assessed for patient eligibility into the trial. This information will be provided by Alfred Pathology to the researchers on the days that vitamin D assays are performed in order to allow researchers to ask patients for consent entering this trial.

Verbal and written education of the Loading Dose Vitamin D project will be presented to the patient or carer to obtain consent into the trial. Finalisation of forms to be confirmed with Alfred ethics.

Computer generated block randomisation will prepared by the Michael Bailey (Alfred statistician) with the use of sealed envelops to minimise investigator bias. Clinical Trial Pharmacy will randomise consented subjects to study group.</concealment>
    <sequence>Computer generated block randomisation</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Vitamin D levels will be taken at baseline and week 12.
Calcium levels will be obtained at baseline and week 12 to monitor for hypercalcemia due to cholecalciferol treatment.</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/02/2010</anticipatedstartdate>
    <actualstartdate>1/02/2010</actualstartdate>
    <anticipatedenddate />
    <actualenddate>1/09/2010</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize>30</actualsamplesize>
    <recruitmentstatus>Terminated</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Alfred Hosptial</primarysponsorname>
    <primarysponsoraddress>Commercial Road Prahran Victoria 3004</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Alfred Hospital</fundingname>
      <fundingaddress>Commercial Road Prahran Victoria 3004</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Monash University</othercollaboratorname>
      <othercollaboratoraddress>381 Royal Parade
Parkville, VIC 3052</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To improve the proportion of elderly patients with moderate to severe vitamin D deficiency reaching target levels above 75nmol/L with the implementation of loading dose vitamin D.

The aim is to test the hypotheses:
Loading dose cholecalciferol 5000units daily will bring higher proportion of patients with moderate to severe deficiency up to target levels(&gt;75nmol/L) compared to 1000units daily.</summary>
    <trialwebsite>nil</trialwebsite>
    <publication>nil</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Alfred Ethics</ethicname>
      <ethicaddress>Alfred Hospital 
Commercial Road Prahran Victoria 3004</ethicaddress>
      <ethicapprovaldate>22/12/2009</ethicapprovaldate>
      <hrec>Project 421/09</hrec>
      <ethicsubmitdate>16/11/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Ms</title>
      <name>Cynthia Kam</name>
      <address>Alfred Hosptial
Commerical Road 
Prahran Victoria 3004</address>
      <phone>+613 9076 2061</phone>
      <fax />
      <email>C.Kam@alfred.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Cynthia Kam</name>
      <address>Alfred Hospital
Commercial Road 
Prahran Victoria 3004</address>
      <phone>+613 9076 2061</phone>
      <fax />
      <email>C.Kam@alfred.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Cynthia Kam</name>
      <address>Alfred Hosptial
Commerical Road 
Prahran Victoria 3004</address>
      <phone>+613 9076 2061</phone>
      <fax />
      <email>C.Kam@alfred.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Cynthia Kam</name>
      <address>Alfred Health
55 Commercial Road
Melbourne VIC 3004
PO Box 315 Prahran
VIC 3181 Australia
</address>
      <phone>+61390762000</phone>
      <fax />
      <email>c.kam@alfred.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>